11-6390705-TGCTGGC-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000543.5(SMPD1):​c.138_143delGCTGGC​(p.Leu47_Ala48del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 1,594,444 control chromosomes in the GnomAD database, including 118,473 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A46A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.29 ( 10346 hom., cov: 0)
Exomes 𝑓: 0.31 ( 108127 hom. )

Consequence

SMPD1
NM_000543.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:11

Conservation

PhyloP100: 0.974
Variant links:
Genes affected
SMPD1 (HGNC:11120): (sphingomyelin phosphodiesterase 1) The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-6390705-TGCTGGC-T is Benign according to our data. Variant chr11-6390705-TGCTGGC-T is described in ClinVar as [Benign]. Clinvar id is 256592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-6390705-TGCTGGC-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMPD1NM_000543.5 linkc.138_143delGCTGGC p.Leu47_Ala48del disruptive_inframe_deletion Exon 1 of 6 ENST00000342245.9 NP_000534.3 P17405-1Q59EN6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMPD1ENST00000342245.9 linkc.138_143delGCTGGC p.Leu47_Ala48del disruptive_inframe_deletion Exon 1 of 6 1 NM_000543.5 ENSP00000340409.4 P17405-1

Frequencies

GnomAD3 genomes
AF:
0.291
AC:
42841
AN:
147156
Hom.:
10331
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.412
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.261
Gnomad EAS
AF:
0.0942
Gnomad SAS
AF:
0.214
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.276
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.291
GnomAD2 exomes
AF:
0.262
AC:
62584
AN:
238972
AF XY:
0.265
show subpopulations
Gnomad AFR exome
AF:
0.351
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.277
Gnomad EAS exome
AF:
0.105
Gnomad FIN exome
AF:
0.260
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.281
GnomAD4 exome
AF:
0.306
AC:
442170
AN:
1447162
Hom.:
108127
AF XY:
0.305
AC XY:
219484
AN XY:
719678
show subpopulations
Gnomad4 AFR exome
AF:
0.365
AC:
12105
AN:
33136
Gnomad4 AMR exome
AF:
0.167
AC:
7382
AN:
44314
Gnomad4 ASJ exome
AF:
0.274
AC:
7065
AN:
25798
Gnomad4 EAS exome
AF:
0.103
AC:
4068
AN:
39490
Gnomad4 SAS exome
AF:
0.267
AC:
22817
AN:
85418
Gnomad4 FIN exome
AF:
0.269
AC:
13924
AN:
51716
Gnomad4 NFE exome
AF:
0.323
AC:
355719
AN:
1101960
Gnomad4 Remaining exome
AF:
0.295
AC:
17610
AN:
59638
Heterozygous variant carriers
0
14325
28650
42974
57299
71624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9964
19928
29892
39856
49820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.291
AC:
42899
AN:
147282
Hom.:
10346
Cov.:
0
AF XY:
0.284
AC XY:
20431
AN XY:
71944
show subpopulations
Gnomad4 AFR
AF:
0.356
AC:
0.356133
AN:
0.356133
Gnomad4 AMR
AF:
0.193
AC:
0.192893
AN:
0.192893
Gnomad4 ASJ
AF:
0.261
AC:
0.260522
AN:
0.260522
Gnomad4 EAS
AF:
0.0942
AC:
0.0941623
AN:
0.0941623
Gnomad4 SAS
AF:
0.216
AC:
0.215517
AN:
0.215517
Gnomad4 FIN
AF:
0.241
AC:
0.241121
AN:
0.241121
Gnomad4 NFE
AF:
0.302
AC:
0.302051
AN:
0.302051
Gnomad4 OTH
AF:
0.289
AC:
0.288725
AN:
0.288725
Heterozygous variant carriers
0
1156
2312
3469
4625
5781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.372

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Sep 02, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The SMPD1 c.138_143delGCTGGC (p.Leu47_Ala48del) variant involves an in-frame deletion of 6 nucleotides located in a known repeat region. Mutation taster predicts a benign outcome for this variant. This variant was found in 24716/110368 control chromosomes (6066 homozygotes), being most prevalent in the African subpopulation with a frequency of 0.3228346 (2706/8382). This frequency greatly exceeds the estimated maximal expected allele frequency of a pathogenic SMPD1 variant (0.0022361), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. Multiple publications consider variant as a polymorphism. Considering the high frequency of the variant in the general population, it was classified as benign. -

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jul 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Niemann-Pick disease, type B Benign:2
May 04, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

African/African American population allele frequency is 34.25% (rs1050228, 7876/22434 alleles, 1698 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as BENIGN. Following criteria are met: BA1 -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Niemann-Pick disease, type A Benign:2
May 15, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SMPD1-related disorder Benign:1
Aug 05, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=192/8
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3838786; hg19: chr11-6411935; COSMIC: COSV54966198; COSMIC: COSV54966198; API